We extracted the seven most common checkpoints (BTLA, CD274, CD276, CTLA4, LAG3, PDCD1, and PDCD1LG2) in immunotherapy into Figure 8B, which shows that CD274 has a positive connection with high expression of JAM-A and LAG3 has a negative connection in most cancers. This evidence concerns the gene CD276 and cancer.